FDA
approval
· 2024-12-05
FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
Summary
The FDA approved a supplemental application for Reyataz (atazanavir) from E.R. Squibb & Sons, L.L.C., updating the labeling as part of an approved supplemental …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for REYATAZ (ATAZANAVIR)